Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adjuvant group
Sponsor: Yonsei University
Completed - verified January 2009
Conditions: Breast Cancer; Lung Cancer; Renal Cancer; Adrenal Cancer
Intervention: Drug: F-18 Paclitaxel (FPAC)
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Gemcitabine, nab-Paclitaxel, GDC-0449
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Stand Up To Cancer; Genentech; Abraxis BioScience Inc.
Not yet recruiting - verified March 2010
Conditions: Kidney Neoplasm; Cysts; Carcinoma, Renal Cell
Intervention: Procedure: partial or radical nephrectomy
Sponsor: Seoul National University Hospital
Completed - verified March 2010
Condition: Pancreatic Adenocarcinoma
Interventions: Device: Gemcitabine + regional hyperthermia; Drug: Gemcitabine
Sponsors: Klinikum der Universitaet Muenchen, Grosshadern; European Society for Hyperthermic Oncology; Institute for Medical Informatics, Biometry and Epidemiology, Munich; ClinAssess GmbH, Leverkusen, Germany
Not yet recruiting - verified March 2010
Conditions: Squamous Cell Carcinoma; Adenocarcinoma; Esophageal Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: carboplatin; Drug: Paclitaxel; Drug: Panitumumab; Radiation: 3-D conformal radiation
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified July 2009
Condition: Adenocarcinoma of the Breast
Intervention:
Sponsor: Indiana University
Not yet recruiting - verified February 2010
Condition: Liver Cancer
Interventions: Drug: iodinated contrast dye; Drug: motexafin gadolinium; Other: laboratory biomarker analysis
Sponsors: American College of Radiology Imaging Network; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Conditions: Cognitive/Functional Effects; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: systemic chemotherapy; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: quality-of-life assessment
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Biological: ramucirumab; Drug: irinotecan hydrochloride
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Liver Cancer
Interventions: Drug: temsirolimus; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: quality-of-life assessment; Radiation: fludeoxyglucose F 18
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified March 2010
Condition: Prostate Cancer
Interventions: Drug: temsirolimus; Biological: bevacizumab; Genetic: polymorphism analysis; Other: laboratory biomarker analysis
Sponsors: Case Comprehensive Cancer Center; The Cleveland Clinic; Ireland Cancer Center
Recruiting - verified March 2010
Condition: Hepatocellular Cancer
Intervention:
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Drug: ixabepilone; Procedure: adjuvant therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Simmons Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Condition: Pancreatic Cancer
Intervention: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - verified March 2010
Condition: Carcinoma, Hepatocellular
Intervention: Device: Ablation with the NanoKnife Irreversible Electroporation (IRE) System
Sponsor: Angiodynamics, Inc.
Recruiting - verified March 2010
Conditions: Renal Cell Cancer; Cancer
Intervention: Drug: Nelfinavir and temsirolimus
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified June 2009
Condition: Liver Cancer
Intervention: Device: Theraspheres
Sponsors: Stanford University; MDS Nordion, Inc.
Available - verified February 2010
Condition: Liver Cancer
Interventions: Drug: pravastatin; Drug: sorafenib tosylate; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Procedure: quality-of-life assessment
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified February 2010
Condition: Advanced Renal Cell Carcinoma
Interventions: Drug: Tivozanib; Drug: Sorafenib
Sponsor: AVEO Pharmaceuticals, Inc.
Not yet recruiting - verified February 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Biological: pegfilgrastim; Drug: bortezomib; Drug: carboplatin; Other: pharmacological study
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Conditions: Metastatic Renal Cell Carcinoma; Gastrointestinal Stromal Tumors
Intervention: Drug: Sunitinib malate
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Drug: HDAC inhibitor SB939; Other: laboratory biomarker analysis
Sponsor: NCIC Clinical Trials Group
Recruiting - verified February 2010
Condition: Cervical Cancer
Interventions: Genetic: proteomic profiling; Other: laboratory biomarker analysis
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Conditions: Kidney Cancer; Renal Cell Carcinoma
Interventions: Biological: Vitespen (HSPPC-96); Biological: Vitespen (HSPPC-96)
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified February 2010
Condition: Liver Cancer
Interventions: Drug: sorafenib tosylate; Drug: vorinostat
Sponsors: Virginia Commonwealth University; Massey Cancer Center
Not yet recruiting - verified March 2010
All Categories ... Medical Conditions » ... Cancers 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
